Cargando…
Scleromyxedema, a therapeutic dilemma
Scleromyxedema is characterized by indurated erythematous papules disseminated on the face, chest and limbs. About twenty cases treated with thalidomide, stem cells, melphalan and immunoglobulin with varying results have been described. We present the case of a 28-year-old male patient diagnosed wit...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372950/ https://www.ncbi.nlm.nih.gov/pubmed/25814746 http://dx.doi.org/10.4103/0019-5154.152600 |
| _version_ | 1782363262201888768 |
|---|---|
| author | Salas-Alanis, Julio Cesar Martinez-Jaramillo, Brayant Gomez-Flores, Minerva Ocampo-Candiani, Jorge |
| author_facet | Salas-Alanis, Julio Cesar Martinez-Jaramillo, Brayant Gomez-Flores, Minerva Ocampo-Candiani, Jorge |
| author_sort | Salas-Alanis, Julio Cesar |
| collection | PubMed |
| description | Scleromyxedema is characterized by indurated erythematous papules disseminated on the face, chest and limbs. About twenty cases treated with thalidomide, stem cells, melphalan and immunoglobulin with varying results have been described. We present the case of a 28-year-old male patient diagnosed with scleromyxedema not associated with monoclonal gammopathy, multi-treated with anti-leprosy drugs, UVA1, and thalidomide for 4 years with no improvement. |
| format | Online Article Text |
| id | pubmed-4372950 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | Medknow Publications & Media Pvt Ltd |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-43729502015-03-26 Scleromyxedema, a therapeutic dilemma Salas-Alanis, Julio Cesar Martinez-Jaramillo, Brayant Gomez-Flores, Minerva Ocampo-Candiani, Jorge Indian J Dermatol E-IJD Case Report Scleromyxedema is characterized by indurated erythematous papules disseminated on the face, chest and limbs. About twenty cases treated with thalidomide, stem cells, melphalan and immunoglobulin with varying results have been described. We present the case of a 28-year-old male patient diagnosed with scleromyxedema not associated with monoclonal gammopathy, multi-treated with anti-leprosy drugs, UVA1, and thalidomide for 4 years with no improvement. Medknow Publications & Media Pvt Ltd 2015 /pmc/articles/PMC4372950/ /pubmed/25814746 http://dx.doi.org/10.4103/0019-5154.152600 Text en Copyright: © Indian Journal of Dermatology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | E-IJD Case Report Salas-Alanis, Julio Cesar Martinez-Jaramillo, Brayant Gomez-Flores, Minerva Ocampo-Candiani, Jorge Scleromyxedema, a therapeutic dilemma |
| title | Scleromyxedema, a therapeutic dilemma |
| title_full | Scleromyxedema, a therapeutic dilemma |
| title_fullStr | Scleromyxedema, a therapeutic dilemma |
| title_full_unstemmed | Scleromyxedema, a therapeutic dilemma |
| title_short | Scleromyxedema, a therapeutic dilemma |
| title_sort | scleromyxedema, a therapeutic dilemma |
| topic | E-IJD Case Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372950/ https://www.ncbi.nlm.nih.gov/pubmed/25814746 http://dx.doi.org/10.4103/0019-5154.152600 |
| work_keys_str_mv | AT salasalanisjuliocesar scleromyxedemaatherapeuticdilemma AT martinezjaramillobrayant scleromyxedemaatherapeuticdilemma AT gomezfloresminerva scleromyxedemaatherapeuticdilemma AT ocampocandianijorge scleromyxedemaatherapeuticdilemma |